Maes, M., al., e. Parkinson’s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways,
, .
Maes, M., al., e. .
Parkinson’s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways.
: , .
Maes, M., al., e. ()
Parkinson’s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways,
:
Maes, M., & al., e.
().
Parkinson’s disease is accompanied by intertwined alterations in iron metabolism and activated immune-inflammatory and oxidative stress pathways. CNS and Neurological Disorders - Drug Targets; CNS and Neurological Disorders - Drug Targets.